WST logo

WST

West Pharmaceutical Services Inc.

$246.95
+$1.50(+0.61%)
47
Overall
55
Value
54
Tech
34
Quality
Market Cap
$17.58B
Volume
462.98K
52W Range
$187.43 - $352.33
Target Price
$316.82
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$1.4B$1.5B$1.6B$1.7B$1.8B$2.1B$2.8B$2.9B$2.9B$2.9B
Total Revenue
$1.4B$1.5B$1.6B$1.7B$1.8B$2.1B$2.8B$2.9B$2.9B$2.9B
COST OF GOODS SOLD
Cost of Revenue
$944.0M$1.0B$1.1B$1.2B$1.2B$1.4B$1.7B$1.8B$1.8B$1.9B
GROSS PROFIT
Gross Profit
$455.8M$501.1M$512.9M$545.4M$605.7M$767.8M$1.2B$1.1B$1.1B$998.5M
OPERATING EXPENSES
Operating Expenses
$327.2M$304.3M$287.1M$305.1M$309.1M$360.9M$407.7M$375.4M$421.8M$407.6M
Research & Development
$34.1M$36.8M$39.1M$40.3M$38.9M$46.9M$52.8M$58.5M$68.4M$69.1M
Research Expense
$34.1M$36.8M$39.1M$40.3M$38.9M$46.9M$52.8M$58.5M$68.4M$69.1M
Selling, General & Administrative
$233.0M$239.8M$246.0M$262.9M$272.7M$302.0M$362.8M$316.9M$353.4M$338.5M
Selling & Marketing Expenses
$233.0M$239.8M$246.0M$262.9M$272.7M$302.0M--------
General & Administrative Expenses
$-10.5M$-11.7M$-13.3M$-14.5M$-17.0M$-17.4M$362.8M$316.9M$353.4M$338.5M
Salaries & Wages
$60.1M$27.7M$2.0M$1.9M$-2.5M$12.0M$-7.9M--$23.3M$18.7M
Depreciation & Amortization
$-89.9M$-90.7M$-96.7M$-104.4M$-103.4M$-109.1M$122.3M$120.6M$137.3M$155.4M
Depreciation & Amortization
$-89.9M$-90.7M$-96.7M$-104.4M$-103.4M$-109.1M$122.3M------
Amortization
$-3.5M$-2.6M$-2.4M$-2.7M$-3.4M$-4.4M$109.9M$107.3M$108.5M$106.9M
Other Operating Expenses
$-800.0K$-1.0M$-400.0K$-4.8M$-12.9M$-12.8M$-16.3M$-600.0K$1.3M$900.0K
OPERATING INCOME
Operating income
$128.6M$196.8M$225.8M$240.3M$296.6M$406.9M$752.3M$734.0M$676.0M$569.9M
EBITDA
$225.9M$296.8M$336.1M$361.1M$412.6M$518.6M$879.4M$829.1M$862.0M$758.6M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$14.1M$8.1M$7.8M$8.4M$8.5M$8.2M$8.2M$7.9M$9.0M$3.0M
Intinc
--------$-4.8M$-5.6M--------
Net Non-Operating Interest Income/Expense
$-12.5M$-7.0M$-6.5M$-6.3M$-4.7M$-6.8M$-8.2M$2.8M$-5.8M$-29.4M
Gain on Sale of Securities
----$-11.1M----$-2.5M$1.0M$5.1M$28.0M$19.6M
Other Income/Expense
$-5.8M$-8.2M$-12.3M$-14.3M$-8.8M$-18.6M$-24.9M$-78.1M$-48.7M$-33.3M
Other Special Charges
$1.5M$2.3M$3.1M$6.7M$-100.0K$1.2M$3.8M$-51.3M$3.0M$-1.0M
SPECIAL ITEMS
Restructring And Mn A Income
--$-26.4M--$-9.1M$-4.9M$-4.6M$2.2M$23.8M$-2.8M$-2.5M
Special Income Charges
$10.9M$43.7M--$11.3M$5.2M$4.6M$-2.2M$-6.0M$-6.8M$-4.8M
Impairment of Capital Assets
--$-17.3M--$-2.2M$-300.0K----$6.2M$9.6M$7.3M
PRE-TAX INCOME
EBIT
$136.0M$206.1M$239.4M$256.7M$309.2M$409.5M$757.1M$708.5M$724.7M$603.2M
Pre-Tax Income
$121.9M$198.0M$231.6M$248.3M$300.7M$418.7M$748.9M$679.9M$698.0M$585.5M
INCOME TAX
Tax Provision
$26.3M$54.4M$80.9M$41.4M$59.0M$72.5M$107.2M$114.7M$122.3M$107.5M
NET INCOME
Net Income
$95.6M$143.6M$150.7M$206.9M$241.7M$346.2M$661.8M$585.9M$593.4M$492.7M
Net Income (Continuing Operations)
$95.6M$143.6M$150.7M$206.9M$241.7M$346.2M$661.8M$585.9M$593.4M$492.7M
Net Income (Discontinued Operations)
$95.6M$143.6M$150.7M$206.9M$241.7M$346.2M$661.8M$585.9M$593.4M$492.7M
Net Income (Common Stockholders)
$95.6M$143.6M$150.7M$206.9M$241.7M$346.2M$661.8M$585.9M$593.4M$492.7M
Normalized Income
--------$227.6M$317.3M----$572.1M$589.5M
TOTALS
Total Expenses
$1.3B$1.3B$1.4B$1.5B$1.5B$1.7B$2.1B$2.1B$2.2B$2.3B
SHARE & EPS DATA
Average Shares Outstanding
$72.0M$73.3M$73.9M$73.9M$74.0M$73.9M$74.4M$74.4M$74.3M$73.0M
Average Shares Outstanding (Diluted)
$73.8M$75.0M$75.8M$75.4M$75.4M$75.8M$76.3M$75.8M$75.3M$73.7M
Shares Outstanding
$72.3M$73.3M$74.0M$74.2M$73.8M$74.1M$74.3M$74.1M$73.3M$72.3M
Basic EPS
$1.33$1.96$2.04$2.8$3.27$4.68$8.89$7.87$7.98$6.75
Basic EPS (Continuing Operations)
------------$8.89$7.87$7.98$6.75
Diluted EPS
$1.3$1.91$1.99$2.74$3.21$4.57$8.67$7.73$7.88$6.69
Diluted EPS (Continuing Operations)
------------$8.67$7.73$7.88$6.69
Dividend Per Share
$0.46$0.50$0.54$0.58$0.62--$0.70$0.73$0.77$0.82
OTHER METRICS
Earnings from equity interest
$5.8M$8.2M$9.2M$7.6M$8.9M$17.4M$20.1M$20.7M$17.7M$14.7M
Earnings From Equity Interest Net Of Tax
$5.8M$8.2M$9.2M$7.6M$8.9M$17.4M$20.1M$20.7M$17.7M$14.7M
Gain On Sale Of Business
$-50.4M------------------
Gain On Sale Of P P E
------$1.1M$1.9M------$-11.6M--
Non Recurring Operation Expense
$-10.9M------------------
Other Gand A
$-10.5M$-11.7M$-13.3M$-14.5M$-17.0M$-17.4M$362.8M$316.9M$353.4M$338.5M
Other Impairment Of Capital Assets
--------$-800.0K$-7.7M$4.6M------
Rent And Landing Fees
$-10.5M$-11.7M$-13.3M$-14.5M------------
Selling Expense
$233.0M$239.8M$246.0M$262.9M$272.7M$302.0M--------
Restruct
--$-26.4M--$-9.1M$-4.9M$-4.6M$2.2M$23.8M$-2.8M$-2.5M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2WST$246.95+0.6%462.98K
3
4
5
6

Get West Pharmaceutical Services Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.